MCV4 is a vaccine used for the prevention of N. meningitides
(Lta). Our MCV4 candidate is a potential first-in-class vaccine
in China. Meningococcal polysaccharide vaccines are primarily
used in China. Developed countries have replaced polysaccharide
products with MCV4 products. As of the Latest Practicable Date,
there was no approved MCV4 in China.
Copyright © ( 2017) CanSino Biologics Inc
For the record: 津ICP备14006666号-2